Ethris Logo - 搜索

时间不限

在新选项卡中打开链接

Ethris Logo的图片

Ethris at the Swiss Biotech Day

swissbiotechday.ch

Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA ...

businesswire.com

Ethris - BIO International Convention | BIO

bio.org

Working at ethris | Glassdoor

glassdoor.com

Ethris Announces Positive Scientific Review of its mRNA-Based COVID-19 Therapeutic Program ...

businesswire.com

Ethris Announces Expansion of Leadership Team | Business Wire

businesswire.com

Ethris and Munster University Hospital Receive ZIM Grant for Rare Pulmonary Disease Research ...

businesswire.com

eTheRNA - Research - Overview, Competitors, and Employees | Apollo.io

apollo.io

DIOSynVax and Ethris Publish Preclinical Proof of Concept for Their Broadly Protective Vaccine ...

newswav.com

Projekte - CNATM

cnatm.de

Jobs at Ethris GmbH | JOIN

join.com

Gründergalerie - TUM

tum.de

ethris GmbH | LinkedIn

linkedin.com

Ethris Company Profile 2024: Valuation, Funding & Investors | PitchBook

pitchbook.com

DIOSynVax and Ethris Publish Preclinical Proof of Concept for Their Broadly Protective Vaccine ...

samedanltd.com

Working at ethris | Glassdoor

synapse-zhihuiya-com.libproxy1.nus.edu.sg

REANIMA 2020 - Network

reanima2020.eu

TUM Start-up Wall - TUM

tum.de

About | ETHRIS

ethris.com

Portfolio — Vannomaden

vannomaden.de

eTheRNA immunotherapies | Apollo

apollo.io

2023 Cilia, Mucus and Mucociliary Interactions Conference GRC

grc.org

Ethris doses first patient with antiviral mRNA drug in Phase I asthma trial

msn.com

Ethis Indonesia | World’s leading ethical investment crowdfunding platform

Copilot 答案
ETHRIS
https://www.ethris.com
Home | ETHRIS
Ethris has created a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA (SNIM mRNA) and lipidoid nanoparticle (SNaP LNP) technology platforms to discover, design and …
KittoKatsu – ethris Identity
ethris entwickelt die Zukunft der Behandlung seltener Krankheiten. Selbstbewusst und dynamisch darf sich diese Errungenschaft im Logo au…
kittokatsu.de
What is ethris' goal?
Ethris’ goal is to become the leader in inhaled mRNA therapeutics. Ethris is seeking to forge strategic partnerships and licensing arrangements with companies that share our vision of advancing the development of innovative mRNA-based therapies and vaccines. This website uses cookies.
ethris.com
About - ETHRIS
About Ethris. Based in Planegg just outside Munich, Germany, Ethris was founded by Dr. Carsten Rudolph and Prof. Christian Plank to establish messenger RNA (mRNA) as a new drug modality. As an mRNA pioneer, we are applying our unique, proprietary SNIM® RNA platform and our proprietary lipidoid nanoparticle (LNP) formulation and delivery ...
ETHRIS · https://www.ethris.com/about
反馈
谢谢!告诉我们更多信息

kittokatsu.de
https://www.kittokatsu.de › corporate_desig…
KittoKatsu – ethris Identity
ethris entwickelt die Zukunft der Behandlung seltener Krankheiten. Selbstbewusst und dynamisch darf sich diese Errungenschaft im Logo ausdrücken.
ETHRIS
https://www.ethris.com › about
About - ETHRIS
About Ethris. Based in Planegg just outside Munich, Germany, Ethris was founded by Dr. Carsten Rudolph and Prof. Christian Plank to establish messenger RNA (mRNA) as a new drug …
缺失:
- Logo
必须包含:
- Logo
LinkedIn
https://www.linkedin.com › company › ethris-gmbh
Ethris - LinkedIn
Ethris Biotechnology Ethris is paving a new path from genes to therapeutic proteins using its proprietary messenger RNA technology platform.
缺失:
- Logo
必须包含:
- Logo
CrunchBase
https://www.crunchbase.com › organization › ethris-gmbh
ETHRIS - Crunchbase Company Profile & Funding
ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. …
- 成立日期: 2009年1月1日
- 位置: Planegg, Bayern
缺失:
- Logo
必须包含:
- Logo
Where is ETHRIS's headquarters?
ETHRIS is located in Planegg, Bayern, Germany.
Who invested in ETHRIS?
ETHRIS has 6 investors including Cipla And Laureus Capital.
How much funding has ETHRIS raised to date?
ETHRIS has raised €79.8M.
When was the last funding round for ETHRIS?
ETHRIS closed its last funding round on Dec 29, 2022 from a Corporate Round round.
Who are ETHRIS's competitors?
Alternatives and possible competitors to ETHRIS may include Nutcracker Therapeutics, Memo Therapeutics, And Slingshot Biosciences.
voasg.com
https://voasg.com › finance
伊思瑞斯启动人体首次给药研究,评估ETR47治疗病毒引起的哮喘的I …
2023年12月18日 · ETH47是一种首创的广谱抗病毒候选药物,通过Ethris的专有平台技术开发用于治疗和预防病毒性哮喘加重 ( SeaPRwire ) – 2023年12月18日, 德国慕尼黑——Ethris公司今天宣 …
缺失:
- Logo
必须包含:
- Logo
其他用户还问了以下问题
What is ethris mRNA?
ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. SNIM®RNAis a first-in-class biopharmaceutical which provide a compelling alternative for recombinant protein or gene therapies. SNIM®RNAs encode therapeutic proteins
ETHRIS - Crunchbase Company Profile & Funding
crunchbase.com
How many followers does ethris have?
Ethris | 3,659 followers on LinkedIn. Ethris is paving a new path from genes to therapeutic proteins using its proprietary messenger RNA technology platform. | Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology.
Ethris - LinkedIn
linkedin.com
What is ethris' goal?
Ethris’ goal is to become the leader in inhaled mRNA therapeutics. Ethris is seeking to forge strategic partnerships and licensing arrangements with companies that share our vision of advancing the development of innovative mRNA-based therapies and vaccines. This website uses cookies.
Home | ETHRIS
ethris.com
Where is ethris located?
ETHRIS is located in Planegg, Bayern, Germany. Who invested in ETHRIS? ETHRIS has 6 investors including Cipla and Laureus Capital. How much funding has ETHRIS raised to date? ETHRIS has raised . When was the last funding round for ETHRIS? ETHRIS closed its last funding round on Dec 29, 2022 from a Corporate Round round.
ETHRIS - Crunchbase Company Profile & Funding
crunchbase.com
When did ethris close?
ETHRIS closed its last funding round on Dec 29, 2022 from a Corporate Round round. Who are ETHRIS's competitors? Alternatives and possible competitors to ETHRIS may include Scholar Rock , Nutcracker Therapeutics , and Slingshot Biosciences. ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.
ETHRIS - Crunchbase Company Profile & Funding
crunchbase.com
Is ethris growing?
ETHRIS may be growing as evidenced by the initiation of a first-in-human dosing in a Phase 1 study of ETH47, which indicates progress in their clinical development pipeline. Additionally, the company has developed the SNaP LNP platform, a new formulation and delivery vehicle, which suggests an expansion in their product offerings.
ETHRIS - Crunchbase Company Profile & Funding
crunchbase.com
反馈
OrbiMed
https://www.orbimed.com › companies › ethris › ethris-cropped-logo
ethris-cropped-logo – OrbiMed
2023年11月16日 · The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for …
ethrisband.com
https://ethrisband.com
Ethris
Ethris Hoodie - $40.00. Ethris Sticker - $6.00. Contact. Instagram: @ethris.band Facebook: @ethris.band
缺失:
- Logo
必须包含:
- Logo
ETHRIS
https://www.ethris.com › pipeline
Pipeline - ETHRIS
Ethris’ wholly owned pipeline comprises first- or best-in-class mRNA-based product candidates for treatment of asthma and rare pulmonary diseases. The versatility of our technology platform enables us to address an array of diverse …
缺失:

Logo
必须包含:

Logo
dxmultiomics.com
https://dxmultiomics.com › company › ethris
About ETHRIS GMBH | DxMultiomics
With more than a decade as an mRNA pioneer, Ethris is a global leader in delivering stabilized mRNAs directly to the respiratory system via optimised formulation and nebulisation …
其他用户还搜索过
Ethris Logo 的相关搜索
分页
- 1
- 2
- 3
- 4
- 下一页

Ethris Logo的图片

Home | ETHRIS

KittoKatsu – ethris Identity

About - ETHRIS

缺失:

必须包含:

Ethris - LinkedIn

缺失:

必须包含:

ETHRIS - Crunchbase Company Profile & Funding

缺失:

必须包含:

伊思瑞斯启动人体首次给药研究,评估ETR47治疗病毒引起的哮喘的I …

缺失:

必须包含:

ETHRIS - Crunchbase Company Profile & Funding

Ethris - LinkedIn

Home | ETHRIS

ETHRIS - Crunchbase Company Profile & Funding

ETHRIS - Crunchbase Company Profile & Funding

ETHRIS - Crunchbase Company Profile & Funding

ethris-cropped-logo – OrbiMed

Ethris

缺失:

必须包含:

Pipeline - ETHRIS

缺失:

必须包含:

About ETHRIS GMBH | DxMultiomics

Ethris Logo 的相关搜索

ETHRIS GmbH

添加更多信息

Ethris Logo 的相关搜索